Baird analyst Jack Allen reiterated an Outperform rating and $6.00 price target on bluebird bio (NASDAQ: BLUE).The analyst commented: "No ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE